D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 520 KRW 7.03%
Market Cap: 770.2B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dongkook Pharmaceutical Co Ltd
Note Receivable Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Note Receivable
-â‚©25.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Note Receivable
â‚©84.8m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Note Receivable
â‚©19.5B
CAGR 3-Years
52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Note Receivable
â‚©6.6B
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Note Receivable
â‚©130.7m
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
-27%

See Also

What is Dongkook Pharmaceutical Co Ltd's Note Receivable?
Note Receivable
-25.3m KRW

Based on the financial report for Jun 30, 2024, Dongkook Pharmaceutical Co Ltd's Note Receivable amounts to -25.3m KRW.

Back to Top